| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/14/2002 | US20020019996 Nucleotide sequences associated with response to gravity in plants; for use in the generation of plant organs |
| 02/14/2002 | US20020019519 KIAA0551 polynucleotides and polypeptides use |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019348 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/14/2002 | US20020019342 In vitro modification of glycosylation patterns of recombinant glycopeptides |
| 02/14/2002 | US20020019060 Device for analyzing a fluid sample |
| 02/14/2002 | US20020019043 Treating inflammatory bowel disease in humans; obtain human, administer drug, monitor for reduction in side effects from gastrointestinal disorder |
| 02/14/2002 | US20020019042 Storing microorganisms with preferential enzymatic activity; obtain microorganisms, incubate in storage solution, monitor microorganisms for preferential enzymatic activity |
| 02/14/2002 | US20020019039 A chemically modified mutant protein, e.g. an enzyme, having a substituted cysteine reacted with a glyosyslated thiosulfate; high esterase activity and low amidase activity of subtilisins; protease to degrade lectins |
| 02/14/2002 | US20020019035 Cell lysis device |
| 02/14/2002 | US20020019033 Polynucleotides encoding chemokine beta-15 |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018770 Method for administering viable microorganism composition for poultry |
| 02/14/2002 | US20020018764 Antifouling agents; coating marine structures |
| 02/14/2002 | US20020017314 Parts washing system |
| 02/14/2002 | DE10037612A1 New phosphopentose isomerase gene from Coryneform bacteria, useful for transforming cells for improved fermentative production of L-amino acids, especially lysine |
| 02/14/2002 | DE10037611A1 New ribulose-phosphate 3-epimerase gene from coryneform bacteria, useful for transforming cells for improved fermentative production of L-amino acids, especially lysine |
| 02/14/2002 | DE10037270A1 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| 02/14/2002 | CA2820132A1 2,5-dkg permeases |
| 02/14/2002 | CA2419066A1 Food supplement |
| 02/14/2002 | CA2418952A1 A novel member of the lysyl oxidase gene family |
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2418370A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 02/14/2002 | CA2418352A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2417970A1 2,5-dkg permeases |
| 02/14/2002 | CA2417969A1 Enhancement of industrial production by increasing substrate transport |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417722A1 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417589A1 Motor proteins and methods for their use |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417368A1 Suppressor gene |
| 02/14/2002 | CA2417357A1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 02/14/2002 | CA2416982A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | CA2416434A1 3-hydroxycarboxylic acid production and use in branched polymers |
| 02/14/2002 | CA2386103A1 Vascular endothelial growth factor 2 |
| 02/13/2002 | EP1179597A1 Method for producing threonine and isoleucine |
| 02/13/2002 | EP1179595A1 (r)-2-octanol dehydrogenase, process for producing the enzyme, dna encoding the enzyme and process for producing alcohol by using the same |
| 02/13/2002 | EP1179593A1 Process for producing recombinant insulin from novel fused protein |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179590A1 Meg-3 protein |
| 02/13/2002 | EP1179588A1 Human brain carboxypeptidase b |
| 02/13/2002 | EP1179586A1 Simple culture medium and method for preparation thereof |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179347A1 Liver function controlling agents |
| 02/13/2002 | EP1179093A1 Expression of ets-domain proteins in cancer |
| 02/13/2002 | EP1179078A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/13/2002 | EP1179076A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 02/13/2002 | EP1179075A2 Bacillus circulans xylanase mutants |
| 02/13/2002 | EP1179071A2 Regulating organelle homeostasis in a cell factory |
| 02/13/2002 | EP1179069A1 GENE ISOLATED FROM $i(RICINUS COMMUNIS) ENCODING A NEW PROTEIN THAT INTERACTS WITH THE OLEATE 12-HYDROXYLASE ENZYME |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179058A1 Cell concentration and lysate clearance using paramagnetic particles |
| 02/13/2002 | EP1179055A1 Novel phytochelatin synthases and uses therefor |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179021A1 Human gaba b receptor 1 promoters |
| 02/13/2002 | EP1179016A1 Parasite antigens |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |
| 02/13/2002 | EP1179003A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP0866876B1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | CN1335890A High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335885A Powdery compositions of liquid aureobasidium culture, process for producing the same and powdery mixtures by using these composition |
| 02/13/2002 | CN1335884A Interluckin 17-like receptor protein |
| 02/13/2002 | CN1335855A Novel protein, gene encoding the same and method of utilization thereof |
| 02/13/2002 | CN1335854A Compositions and methods for controlling plant pests |
| 02/13/2002 | CN1335450A Petroleum peptide PCR-petroleum enzyme, coenzyme and its special activator |
| 02/13/2002 | CN1335403A Process for producing nucleotide by fermentation |
| 02/13/2002 | CN1335401A Process for producing matter with microbe |
| 02/13/2002 | CN1335394A Generation of L-glutamic acid bacterium and process for producing L-glutamic acid |
| 02/13/2002 | CN1335393A Fermentation production process of alkaline mycose lyase and microbe for producing the lyase |
| 02/13/2002 | CN1335392A Apple wine yeast and its usage in brewing apple wine |
| 02/13/2002 | CN1335391A Saccharomycetes strain for producing erythritol |
| 02/13/2002 | CN1335390A Method of extracting nutrients from papermaking black liquor and compounding edible fungus culturing medium |
| 02/13/2002 | CN1335389A Fermenting culture process of produicng Cordyceps extract |
| 02/13/2002 | CN1335388A Microbe TV-1 and its prepn |
| 02/13/2002 | CN1335288A Bacteria prepn for organic matter to become decomposed fast |